{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:09:04Z","timestamp":1768529344628,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cllc.2011.10.005","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T19:49:30Z","timestamp":1323373770000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Randomized Phase III Trial of Combined Paclitaxel, Carboplatin, and Radiation Therapy Followed by Weekly Paclitaxel or Observation for Patients With Locally Advanced Inoperable Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Dennis L.","family":"Carter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Garfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mundis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi A.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Des","family":"Ilegbodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2011.10.005_bib1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.cllc.2011.10.005_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.117.2.358","article-title":"Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group","volume":"117","author":"Sause","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2011.10.005_bib3","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.1998.16.10.3316","article-title":"Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer","volume":"16","author":"Choy","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib4","first-page":"3429","article-title":"Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma","volume":"22","author":"Nguyen","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2011.10.005_bib5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.1997.15.4.1409","article-title":"Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study","volume":"15","author":"Frasci","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2007.07.012","volume":"59","author":"Rajeswaran","year":"2008","journal-title":"Lung Cancer"},{"issue":"4 suppl 12","key":"10.1016\/j.cllc.2011.10.005_bib7","first-page":"S12","article-title":"Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer","volume":"24","author":"Choy","year":"1997","journal-title":"Semin Oncol"},{"issue":"6 suppl 16","key":"10.1016\/j.cllc.2011.10.005_bib8","first-page":"117","article-title":"Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer","volume":"23","author":"Choy","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0360-3016(00)00420-X","article-title":"A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)","volume":"47","author":"Choy","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2011.10.005_bib10","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1200\/JCO.2005.55.405","article-title":"Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.cllc.2011.10.005_bib11","article-title":"Maintenance therapy (MT) with weekly paclitaxel improves outcome for advanced non-small cell lung cancer (NSCLC) patients","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib13","series-title":"AJCC Cancer Staging Manual","article-title":"Liver","author":"Fleming","year":"1997"},{"key":"10.1016\/j.cllc.2011.10.005_bib14","series-title":"WHO handbook for reporting results of cancer treatment","year":"1979"},{"key":"10.1016\/j.cllc.2011.10.005_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.cllc.2011.10.005_bib16","first-page":"85","article-title":"Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A\/B) non-small cell lung cancer (NSCLC): a preliminary report","volume":"83","author":"Ratanatharathorn","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.cllc.2011.10.005_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0169-5002(00)00171-9","article-title":"Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer","volume":"31","author":"Ratanatharathorn","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2011.10.005_bib18","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2007.14.7371","article-title":"Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105","volume":"26","author":"Socinski","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib19","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2009.24.5050","article-title":"Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non\u2013small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib20","first-page":"495","article-title":"Sequential versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer","volume":"26","author":"El-Sharouni","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2011.10.005_bib21","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie NPC 95-01 Study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl 4","key":"10.1016\/j.cllc.2011.10.005_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-5002(02)00169-1","article-title":"Adjuvant and neoadjuvant treatments for NSCLC","volume":"38","author":"Vokes","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2011.10.005_bib23","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1200\/JCO.2006.07.3569","article-title":"Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small-cell lung cancer: Cancer and Leukemia Group B","volume":"25","author":"Vokes","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib24","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1200\/JCO.2008.17.7840","article-title":"Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology","volume":"26","author":"Hanna","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib25","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1200\/JCO.2007.14.4824","article-title":"Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023","volume":"26","author":"Kelly","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.10.005_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1748-717X-4-5","article-title":"Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer","volume":"4","author":"Sulman","year":"2009","journal-title":"Radiation Oncology"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411002476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411002476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:55:00Z","timestamp":1761504900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411002476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1525730411002476"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2011.10.005","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Phase III Trial of Combined Paclitaxel, Carboplatin, and Radiation Therapy Followed by Weekly Paclitaxel or Observation for Patients With Locally Advanced Inoperable Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2011.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}